Understanding treatments for bone loss and bone metastases in patients with prostate cancer: a practical review and guide for the clinician
-
Published:2004-05
Issue:2
Volume:31
Page:331-352
-
ISSN:0094-0143
-
Container-title:Urologic Clinics of North America
-
language:en
-
Short-container-title:Urologic Clinics of North America
Author:
Higano Celestia S
Reference114 articles.
1. A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate cancer;Saad;J Natl Cancer Inst,2002
2. The potential role of bisphosphonates in prostate cancer;Oades;Prostate Cancer Prostatic Dis,2002
3. Combined analysis of two multicenter, randomized, placebo-controlled studies of pamidronate disodium for the palliation of bone pain in men with metastatic prostate cancer;Small;J Clin Oncol,2003
4. Prostate cancer trends in the era of prostate-specific antigen. An update of incidence, mortality, and clinical factors from the SEER database;Stephenson;Urol Clin North Am,2002
5. Background to and management of treatment-related bone loss in prostate cancer;Berruti;Drugs Aging,2002
Cited by
61 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献